MedTech News
.................... by Andrew Celentano
Specialized RNA molecules could counter ALS neurodegeneration
Misshapen proteins cause a mess of trouble—particularly in neurodegenerative diseases. But a new study suggests it’s possible that giving them a little bit of extra support could keep them working correctly, and even reverse the damage they have caused.
Gold-coated microneedles can detect subtleties in how liver and kidneys process drugs in real time
Scientists have taken a giant leap forward with the development of tiny microneedles designed to detect subtle but critical changes in how the liver and kidneys process therapeutic drugs.
This Substance Is 1,000 Times More Potent Than the World’s Spiciest Pepper — and It Could Provide Pain Relief
Capsaicin, the toxin found in chili peppers, is what many people believe to be the spiciest chemical on Earth. But an ultrapotent form of this chemical made by an unassuming cactus-like plant makes typical capsaicin seem mild in comparison.
FDA clears Bright Uro’s abdominal sensor for evaluating bladder dysfunction
The approval of Bright Uro’s Glean abdominal sensor advances the capabilities of its broader Glean urodynamics system that gained FDA approval in March 2025.
FDA greenlights Rivanna’s AI musculoskeletal imaging system
With FDA clearance in hand, Rivanna highlighted that it will accelerate the development of further AI capabilities for the Accuro XV system.
Nerve-sprouting therapy boosts coordinated walking across spinal cord injury severities in mice
A research group led by Professor Dr. Dietmar Fischer from the Institute of Pharmacology II at University Hospital Cologne is therefore pursuing a new approach to treating such contusion injuries.
Finger-prick blood test may spot active tuberculosis early and predict who develops disease
Researchers assessed whether a blood-based 3-gene host-response test can detect active tuberculosis and help predict future disease.
New implant links insulin-producing cells to blood vessels, aiming to treat Type 1 diabetes
Researchers at McGill University and the Research Institute of the McGill University Health Center (RI-MUHC) have developed a novel device to transplant insulin-producing cells that integrates directly with existing blood vessels in the body.